Theralase TLTFF Stock
Theralase Price Chart
Theralase TLTFF Financial and Trading Overview
| Theralase stock price | 0.19 USD |
| Previous Close | 0.18 USD |
| Open | 0.18 USD |
| Bid | 0.19 USD x 1000000 |
| Ask | 0.19 USD x 6200000 |
| Day's Range | 0.18 - 0.18 USD |
| 52 Week Range | 0.1 - 0.31 USD |
| Volume | 60K USD |
| Avg. Volume | 188.66K USD |
| Market Cap | 55.16M USD |
| Beta (5Y Monthly) | 0.587 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.01 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
TLTFF Valuation Measures
| Enterprise Value | 57.82M USD |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 64.29996 |
| Price/Book (mrq) | 40.48091 |
| Enterprise Value/Revenue | 67.399 |
| Enterprise Value/EBITDA | -16.275 |
Trading Information
Theralase Stock Price History
| Beta (5Y Monthly) | 0.587 |
| 52-Week Change | 42.85% |
| S&P500 52-Week Change | 20.36% |
| 52 Week High | 0.31 USD |
| 52 Week Low | 0.1 USD |
| 50-Day Moving Average | 0.18 USD |
| 200-Day Moving Average | 0.17 USD |
TLTFF Share Statistics
| Avg. Volume (3 month) | 188.66K USD |
| Avg. Daily Volume (10-Days) | 97.09K USD |
| Shares Outstanding | 275.82M |
| Float | 276.45M |
| Short Ratio | N/A |
| % Held by Insiders | 8.40% |
| % Held by Institutions | 0% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2025 |
| Most Recent Quarter (mrq) | March 31, 2026 |
| Next Fiscal Year End | December 31, 2026 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -776.89% |
| Gross Margin | 65.06% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -67.85% |
| Return on Equity (ttm) | -242.19% |
Income Statement
| Revenue (ttm) | 857.91K USD |
| Revenue Per Share (ttm) | 0.003 USD |
| Quarterly Revenue Growth (yoy) | 45.39% |
| Gross Profit (ttm) | 558.22K USD |
| EBITDA | -3552798 USD |
| Net Income Avi to Common (ttm) | -3681352 USD |
| Diluted EPS (ttm) | -0.01 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 1M USD |
| Total Cash Per Share (mrq) | 0.003 USD |
| Total Debt (mrq) | 431.59K USD |
| Total Debt/Equity (mrq) | 22.14 USD |
| Current Ratio (mrq) | 1.371 |
| Book Value Per Share (mrq) | 0.0049406 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -3177526 USD |
| Levered Free Cash Flow (ttm) | -1931414 USD |
Profile of Theralase
| Country | United States |
| State | ON |
| City | Toronto |
| Address | 41 Hollinger Road |
| ZIP | M4B 3G4 |
| Phone | 416 699 5273 |
| Website | https://www.theralase.com |
| Industry | Medical Devices |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
Theralase Technologies Inc., a clinical stage pharmaceutical company, engages in the research, development, and commercialization of energy activated small molecules and associated drug formulations in Canada, the United States, and internationally. The company operates in two segments, Drug Division and Device Division. It engages in the research and development of Rutherrin, an injectable form of Ruvidar for the treatment of glio blastoma multiforme, a form of brain cancer, non-small cell lung cancer, pancreatic cancer, colorectal cancer, and muscle invasive bladder cancer; and Ruvidar, a topical treatment for herpes simplex virus-1 lesions and an extracorporeal treatment for lymphoma, leukemia, and multiple myeloma. The company also researches, develops, manufactures, and distributes Cool Laser Therapy systems to healthcare practitioners for the healing of pain. Theralase Technologies Inc. is based in Toronto, Canada.
Q&A For Theralase Stock
What is a current TLTFF stock price?
Theralase TLTFF stock price today per share is 0.19 USD.
How to purchase Theralase stock?
You can buy TLTFF shares on the OTC Markets OTCQB exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Theralase?
The stock symbol or ticker of Theralase is TLTFF.
Which industry does the Theralase company belong to?
The Theralase industry is Medical Devices.
How many shares does Theralase have in circulation?
The max supply of Theralase shares is 275.82M.
What is Theralase Price to Earnings Ratio (PE Ratio)?
Theralase PE Ratio is now.
What was Theralase earnings per share over the trailing 12 months (TTM)?
Theralase EPS is -0.01 USD over the trailing 12 months.
Which sector does the Theralase company belong to?
The Theralase sector is Healthcare.